FindTrial
Sign In

A test with patients aimed at proving the efficacy of Hycos Dérmico, assisting in the application of wound dressings without damaging the skin affected by the disease.

Single-blind clinical study on the efficacy and safety of the product Hycos Dérmico

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2v3sqdx
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-06-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Interventions

This is a study aimed at proving the efficacy and safety of the product Hycos Dermic, a cream solution intended for skin regeneration. The study was conducted on a single group, single-blind clinical
E05.940.790.500

Sponsors

Instituto de Saúde e Bem estar da Mulher
Lead Sponsor
Nipo Serviços Médicos SS Ltda
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The participating patient has a wound, lesion, or bedsore. The injury requires dressings. Age between 18 and 90 years old. Any ethnicity, color/race, and skin phototype. Both genders. Patients are in the early stages of treatment

Exclusion criteria

Exclusion criteria: Pregnancy. Neonates. Sensitivity to the components of the medication

Design outcomes

Primary

MeasureTime frame
To prove the efficacy and safety of Hycos Dermic in humans affected by first- and second-degree burn wounds.—

Secondary

MeasureTime frame
To demonstrate the potential for use beyond patients affected by burns—

Countries

Brazil

Contacts

Public ContactFrederico Viana

TCI Laboratório Biotecnológico Ltda

frederico@tcilab.com.br+55 38 99886-3565

Outcome results

None listed

Source: REBEC (via WHO ICTRP)